1H-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis

Details for Australian Patent Application No. 2010274921 (hide)

Owner Novartis AG

Inventors Kalkman, Hans O.; Mattes, Henri

Agent Davies Collison Cave

Pub. Number AU-A-2010274921

PCT Pub. Number WO2011/009951

Priority 61/227,940 23.07.09 US

Filing date 23 July 2010

Wipo publication date 27 January 2011

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/009951 Priority application(s): WO2011/009951

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010274924-Wastewater treatment plant and method for treating wastewater, and wastewater treatment system

2010274917-Fluorinated cyclopropane analogs of glutamic acid